The dtect<em>Dx</em> Breast Test for Breast Cancer
Meredith C. Henderson, PhD, Head, R&D, Provista Diagnostics, describes the dtectDx Breast test.
Meredith C. Henderson, PhD, Head, R&D, Provista Diagnostics, describes the dtectDxBreast test.
DtectDxBreast is essentially a blood test for the detection of breast cancer and is meant to be used in conjunction with mammography. With this test, Henderson says, information is available for a physician to make a decision regarding further imaging or biopsying.
DtectDxBreast is especially beneficial for women under 50 years, who tend to be underserved by mammography. The test is also beneficial, Henderson says, as it should not be affected by dense breast tissue or previous biopsy. If imaging is difficult or confounding in a patient, an empirical value from the dtectDxBreast test is still possible.
Clinical Pearls
- The dtectDxBreast test is a blood test for the detection of breast cancer, meant to be used in conjunction with mammography
- Especially beneficial for women under 50 years, who tend to be underserved by mammography
Therapy Type and Site of Metastases Factor into HR+, HER2+ mBC Treatment
December 20th 2024During a Case-Based Roundtable® event, Ian Krop, MD, and participants discussed considerations affecting first- and second-line treatment of metastatic HER2-positive breast cancer in the first article of a 2-part series.
Read More
Imlunestrant Improves PFS in ESR1-Mutant Advanced Breast Cancer
December 13th 2024The phase 3 EMBER-3 trial showed imlunestrant improved PFS over SOC endocrine therapy in ER-positive, HER2-negative advanced breast cancer with ESR1 mutations, though not significantly in the overall population.
Read More
